Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Baker

Showing results (421-430 of 438) with videos related to

Pageof 44
Sort By:
AIDS Care|March 22, 2021
The Global Task Force for Chronic Pain in People with HIV (PWH): Developing a research agenda in an emerging fieldJessica S Merlin, M Hamm, F de Abril Cameron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2022
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III studyA Psyrri, J Fayette, K Harrington, et al.
Cancers|October 13, 2021
Maraviroc Prevents HCC Development by Suppressing Macrophages and the Liver Progenitor Cell Response in a Murine Chronic Liver Disease ModelAdam M Passman, Robyn P Strauss, Sarah B McSpadden, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 3, 2020
Transcriptomic responses from improved murine sepsis models can better mimic human surgical sepsisPhilip A Efron, Dijoia B Darden, Zhongkai Wang, et al.
Plos Medicine|November 29, 2017
Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case studyNathan W Cummins, Stacey Rizza, Mark R Litzow, et al.
AIDS (London, England)|May 31, 2024
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIVLeanne McCabe, James E Burns, Arash Latifoltojar, et al.
Lancet (London, England)|January 11, 2011
High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trialAdrian R Martineau, Peter M Timms, Graham H Bothamley, et al.
Clinical Trials (London, England)|October 11, 2021
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.
Medrxiv : the Preprint Server for Health Sciences|November 20, 2020
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.
The Lancet. Microbe|May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort studyTomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
Pageof 44

Showing results (421-430 of 438) with videos related to

Sort By:
Pageof 44
AIDS Care|March 22, 2021
The Global Task Force for Chronic Pain in People with HIV (PWH): Developing a research agenda in an emerging fieldJessica S Merlin, M Hamm, F de Abril Cameron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2022
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III studyA Psyrri, J Fayette, K Harrington, et al.
Cancers|October 13, 2021
Maraviroc Prevents HCC Development by Suppressing Macrophages and the Liver Progenitor Cell Response in a Murine Chronic Liver Disease ModelAdam M Passman, Robyn P Strauss, Sarah B McSpadden, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 3, 2020
Transcriptomic responses from improved murine sepsis models can better mimic human surgical sepsisPhilip A Efron, Dijoia B Darden, Zhongkai Wang, et al.
Plos Medicine|November 29, 2017
Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case studyNathan W Cummins, Stacey Rizza, Mark R Litzow, et al.
AIDS (London, England)|May 31, 2024
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIVLeanne McCabe, James E Burns, Arash Latifoltojar, et al.
Lancet (London, England)|January 11, 2011
High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trialAdrian R Martineau, Peter M Timms, Graham H Bothamley, et al.
Clinical Trials (London, England)|October 11, 2021
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.
Medrxiv : the Preprint Server for Health Sciences|November 20, 2020
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.
The Lancet. Microbe|May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort studyTomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
Pageof 44